Ampersand Capital Partners has recapitalized New England Peptide, a provider of high-quality custom peptides and antibodies to the global life sciences market. No financial terms were disclosed.
Paradigm Equity Partners acquires upholstery and performance fabric maker STI Fabrics
5 hours ago · 1 min read
KKR and Hildred merge diagnostics businesses Sapphiros and binx health into Onvaro
6 hours ago · 2 mins read
Eir Partners-backed Porter acquires health plan analytics firm Pareto Intelligence
6 hours ago · 1 min read
Bain Capital’s LeanTaaS snaps up hospital care transition platform Aidin
6 hours ago · 2 mins read
Carlyle-backed Vantive agrees hemodialysis business sale to Rockwell Medical
6 hours ago · 2 mins read
Novacap completes OSI Maritime Systems acquisition as first Fund VII deal
6 hours ago · 2 mins read
Long Arc-backed Robertson Stephens adds Denver adviser Altius Financial
6 hours ago · 1 min read
